Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells
This study is currently recruiting participants.
Verified by University of Rostock, December 2006
Sponsors and Collaborators: University of Rostock
MSD Sharp & Dohme GmbH
Information provided by: University of Rostock
ClinicalTrials.gov Identifier: NCT00414739
  Purpose

The study analysis the influence of benzalkonium chloride on the density of antigen presenting Langerhans cells. This is achieved in a double blind randomized study using in-vivo confocal microscopy to identify and quantify Langerhans cells of the human cornea in its central and peripheral part. This study design is based on observations with raised Langerhans cell density after the application of benzalkonium chloride containing eye drops in glaucoma patients.


Condition Intervention Phase
Eye Diseases
Drug: Benzalkonium chloride
Phase I

MedlinePlus related topics: Eye Diseases
Drug Information available for: Chlorides Benzalkonium chloride
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety Study

Further study details as provided by University of Rostock:

Primary Outcome Measures:
  • Possible raised Langerhans cell density in the corneal epithelium

Estimated Enrollment: 20
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy probands

Exclusion Criteria:

  • eye diseases
  • pregnancy and lactation period
  • drug dependency
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00414739

Locations
Germany
University of Rostock, Eye Department Recruiting
Rostock, Germany, 18057
Contact: Rudolf F. Guthoff, Prof. Dr.     +49/(0)381/4948501     rudolf.guthoff@med.uni-rostock.de    
Principal Investigator: Andrey Zhivov, Dr. med.            
Sponsors and Collaborators
University of Rostock
MSD Sharp & Dohme GmbH
Investigators
Study Chair: Rudolf F. Guthoff, Prof. Dr. University of Rostock, Eye Department
  More Information

Publications:
Study ID Numbers: BAC-2006-1
Study First Received: December 21, 2006
Last Updated: December 21, 2006
ClinicalTrials.gov Identifier: NCT00414739  
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by University of Rostock:
growth of dendritic cells
prevention

Study placed in the following topic categories:
Eye Diseases
Benzalkonium Compounds

Additional relevant MeSH terms:
Anti-Infective Agents
Anti-Infective Agents, Local
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009